广康生化
(300804)
| 流通市值：10.77亿 | | | 总市值：28.98亿 |
| 流通股本：2750.00万 | | | 总股本：7400.00万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 398,931,436.58 | 187,242,875.58 | 723,480,846.94 | 484,361,918.38 |
| 营业收入 | 398,931,436.58 | 187,242,875.58 | 723,480,846.94 | 484,361,918.38 |
| 二、营业总成本 | 368,710,516.59 | 172,515,413.01 | 701,124,233 | 468,169,647.03 |
| 营业成本 | 304,664,986.97 | 143,417,378.71 | 573,312,146.13 | 374,610,885.23 |
| 税金及附加 | 982,797.73 | 480,759 | 1,958,832.25 | 1,389,432.02 |
| 销售费用 | 7,889,820.25 | 3,237,565.46 | 13,790,831.47 | 8,363,405.86 |
| 管理费用 | 30,940,583.93 | 14,238,946.4 | 62,909,202.42 | 47,692,670.55 |
| 研发费用 | 16,702,196.66 | 7,635,984.13 | 38,829,391.03 | 27,678,651.99 |
| 财务费用 | 7,530,131.05 | 3,504,779.31 | 10,323,829.7 | 8,434,601.38 |
| 其中:利息费用 | - | 2,636,272.82 | 9,475,419.5 | 7,085,608.43 |
| 其中:利息收入 | - | 28,312.01 | 2,078,234.04 | 1,976,419.94 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | 295,332.05 | - |
| 加:投资收益 | 3,881,934.58 | 2,402,417.9 | 9,382,830.52 | 5,119,688.58 |
| 资产处置收益 | -15,128.49 | -15,128.49 | - | 0 |
| 资产减值损失(新) | - | - | -210,976.17 | - |
| 信用减值损失(新) | -461,953.88 | 650,232.99 | -3,664,074.07 | -4,567,319.12 |
| 其他收益 | 627,036.54 | 317,512.49 | 1,324,480.88 | 939,529.21 |
| 四、营业利润 | 34,252,808.74 | 18,082,497.46 | 29,484,207.15 | 17,684,170.02 |
| 加:营业外收入 | 105,772.41 | 70,059.25 | 12,666,004.2 | 12,095,203.1 |
| 减:营业外支出 | 2,792,744.97 | 82,785.86 | 7,588,902.79 | 4,409,103.81 |
| 五、利润总额 | 31,565,836.18 | 18,069,770.85 | 34,561,308.56 | 25,370,269.31 |
| 减:所得税费用 | 2,496,814.45 | 1,062,344.48 | 315,699.06 | 1,947,388.68 |
| 六、净利润 | 29,069,021.73 | 17,007,426.37 | 34,245,609.5 | 23,422,880.63 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 29,069,021.73 | 17,007,426.37 | 34,245,609.5 | 23,422,880.63 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 29,013,888.44 | 17,109,527.99 | 34,681,288.66 | 23,691,057.28 |
| 少数股东损益 | 55,133.29 | -102,101.62 | -435,679.16 | -268,176.65 |
| 扣除非经常损益后的净利润 | 27,481,322.35 | 14,822,368.68 | 23,052,118.57 | 12,027,247.4 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.39 | 0.23 | 0.47 | 0.32 |
| (二)稀释每股收益 | 0.39 | 0.23 | 0.47 | 0.32 |
| 九、综合收益总额 | 29,069,021.73 | 17,007,426.37 | 34,245,609.5 | 23,422,880.63 |
| 归属于母公司股东的综合收益总额 | 29,013,888.44 | 17,109,527.99 | 34,681,288.66 | 23,691,057.28 |
| 归属于少数股东的综合收益总额 | 55,133.29 | -102,101.62 | -435,679.16 | -268,176.65 |
| 公告日期 | 2025-08-22 | 2025-04-18 | 2025-04-18 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |